(0.25%) 5 144.50 points
(0.26%) 38 540 points
(0.36%) 17 910 points
(-0.78%) $83.20
(1.72%) $1.956
(-0.18%) $2 342.90
(0.07%) $27.27
(0.52%) $926.90
(-0.21%) $0.933
(-0.14%) $11.01
(-0.29%) $0.798
(0.75%) $92.56
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 6.70%
@ $35.07
発行日: 27 4月 2024 @ 03:21
リターン: 0.48%
前回のシグナル: 4月 27 - 02:03
前回のシグナル:
リターン: -0.37 %
Live Chart Being Loaded With Signals
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally...
Stats | |
---|---|
本日の出来高 | 664 758 |
平均出来高 | 1.73M |
時価総額 | 2.28B |
EPS | $0 ( 2024-02-21 ) |
次の収益日 | ( $-0.800 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -10.27 |
ATR14 | $1.050 (2.97%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Carpenter Rick | Buy | 405 | Common Stock |
2024-03-15 | Carpenter Rick | Sell | 145 | Common Stock |
2024-03-15 | Carpenter Rick | Sell | 405 | Restricted Stock Unit |
2024-02-27 | Morrison Susan | Buy | 407 | Common Stock |
2024-02-27 | Morrison Susan | Sell | 113 | Common Stock |
INSIDER POWER |
---|
62.96 |
Last 100 transactions |
Buy: 113 075 | Sell: 24 727 |
ボリューム 相関
Tandem Diabetes Care Inc 相関
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Tandem Diabetes Care Inc 相関 - 通貨/商品
Tandem Diabetes Care Inc 財務諸表
Annual | 2023 |
収益: | $747.72M |
総利益: | $367.69M (49.17 %) |
EPS: | $-3.43 |
FY | 2023 |
収益: | $747.72M |
総利益: | $367.69M (49.17 %) |
EPS: | $-3.43 |
FY | 2022 |
収益: | $801.22M |
総利益: | $412.99M (51.54 %) |
EPS: | $-1.470 |
FY | 2021 |
収益: | $702.80M |
総利益: | $376.22M (53.53 %) |
EPS: | $0.260 |
Financial Reports:
No articles found.
Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。